APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fertility Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fertility Drugs Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchFertility Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Fertility Drugs Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Fertility Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fertility Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Fertility Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Fertility Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fertility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fertility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fertility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fertility Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fertility Drugs market include Abbott, Merck, Ferring, Bayer, Zydus Pharma, MSD and LIVZON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fertility Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fertility Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fertility Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fertility Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Fertility Drugs Segment by Company

Abbott

Merck

Ferring

Bayer

Zydus Pharma

MSD

LIVZON

Fertility Drugs Segment by Type

Gonadotropins

Anti-Estrogens

Other

Fertility Drugs Segment by Application

Male

Female

Fertility Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fertility Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Fertility Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fertility Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Fertility Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fertility Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fertility Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fertility Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fertility Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fertility Drugs industry.

Chapter 3: Detailed analysis of Fertility Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Fertility Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Fertility Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fertility Drugs Industry Trends Table 2. Fertility Drugs Industry Drivers Table 3. Fertility Drugs Industry Opportunities and Challenges Table 4. Fertility Drugs Industry Restraints Table 5. Global Fertility Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fertility Drugs Revenue Share by Company (2021-2026) Table 7. Global Fertility Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Fertility Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Fertility Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Fertility Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Fertility Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Fertility Drugs Company, Product Type & Application Table 13. Global Fertility Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Fertility Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Gonadotropins Table 18. Significant Companies of Anti-Estrogens Table 19. Significant Companies of Other Table 20. Global Fertility Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Fertility Drugs Sales Volume by Type (2021-2026) & (k units) Table 22. Global Fertility Drugs Sales Volume by Type (2027-2032) & (k units) Table 23. Global Fertility Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Fertility Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Fertility Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Fertility Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Fertility Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Fertility Drugs Sales Value Share by Type (2021-2026) Table 29. Global Fertility Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Male Table 31. Significant Companies of Female Table 32. Global Fertility Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Fertility Drugs Sales Volume by Application (2021-2026) & (k units) Table 34. Global Fertility Drugs Sales Volume by Application (2027-2032) & (k units) Table 35. Global Fertility Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Fertility Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Fertility Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Fertility Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Fertility Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Fertility Drugs Sales Value Share by Application (2021-2026) Table 41. Global Fertility Drugs Sales Value Share by Application (2027-2032) Table 42. Global Fertility Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Fertility Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Fertility Drugs Sales Market Share by Region (2021-2026) Table 45. Global Fertility Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Fertility Drugs Sales Market Share by Region (2027-2032) Table 47. Global Fertility Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Fertility Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Fertility Drugs Sales Value Share by Region (2021-2026) Table 50. Global Fertility Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Fertility Drugs Sales Value Share by Region (2027-2032) Table 52. Global Fertility Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Fertility Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Fertility Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Fertility Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Fertility Drugs Sales by Country (2021-2026) & (k units) Table 57. Global Fertility Drugs Sales Market Share by Country (2021-2026) Table 58. Global Fertility Drugs Sales by Country (2027-2032) & (k units) Table 59. Global Fertility Drugs Sales Market Share by Country (2027-2032) Table 60. Global Fertility Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Fertility Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Fertility Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Fertility Drugs Sales Value Market Share by Country (2027-2032) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Fertility Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Abbott Fertility Drugs Product Portfolio Table 68. Abbott Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Fertility Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Merck Fertility Drugs Product Portfolio Table 73. Merck Recent Development Table 74. Ferring Company Information Table 75. Ferring Business Overview Table 76. Ferring Fertility Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Ferring Fertility Drugs Product Portfolio Table 78. Ferring Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer Fertility Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Bayer Fertility Drugs Product Portfolio Table 83. Bayer Recent Development Table 84. Zydus Pharma Company Information Table 85. Zydus Pharma Business Overview Table 86. Zydus Pharma Fertility Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Zydus Pharma Fertility Drugs Product Portfolio Table 88. Zydus Pharma Recent Development Table 89. MSD Company Information Table 90. MSD Business Overview Table 91. MSD Fertility Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. MSD Fertility Drugs Product Portfolio Table 93. MSD Recent Development Table 94. LIVZON Company Information Table 95. LIVZON Business Overview Table 96. LIVZON Fertility Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. LIVZON Fertility Drugs Product Portfolio Table 98. LIVZON Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Fertility Drugs Distributors List Table 102. Fertility Drugs Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Fertility Drugs Product Image Figure 2. Global Fertility Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Fertility Drugs Sales (2021-2032) & (k units) Figure 5. Global Fertility Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Fertility Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gonadotropins Image Figure 10. Anti-Estrogens Image Figure 11. Other Image Figure 12. Global Fertility Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Fertility Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Fertility Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Fertility Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Fertility Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Fertility Drugs Sales Value Share by Type (2021-2032) Figure 18. Male Image Figure 19. Female Image Figure 20. Global Fertility Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Fertility Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Fertility Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Fertility Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Fertility Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Fertility Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Fertility Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Fertility Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Fertility Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Fertility Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Fertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Fertility Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Fertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Fertility Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Fertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Fertility Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Fertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Fertility Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Fertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Fertility Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Fertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Fertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Fertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Fertility Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Fertility Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Gonadotropins
  • Anti-Estrogens
  • Other
Applications
  • Male
  • Female
Companies covered
  • Abbott
  • Merck
  • Ferring
  • Bayer
  • Zydus Pharma
  • MSD
  • LIVZON

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fertility Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Fertility Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Fertility Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Fertility Drugs Market Dynamics
  1. 2.1 Fertility Drugs Industry Trends
  2. 2.2 Fertility Drugs Industry Drivers
  3. 2.3 Fertility Drugs Industry Opportunities and Challenges
  4. 2.4 Fertility Drugs Industry Restraints
3 Fertility Drugs Market by Company
  1. 3.1 Global Fertility Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Fertility Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Fertility Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Fertility Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Fertility Drugs Company Ranking (2024-2026)
  6. 3.6 Global Fertility Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Fertility Drugs Company Product Type and Application
  8. 3.8 Global Fertility Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Fertility Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Fertility Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Fertility Drugs Market by Type
  1. 4.1 Fertility Drugs Type Introduction
  2. 4.1.1 Gonadotropins
  3. 4.1.2 Anti-Estrogens
  4. 4.1.3 Other
  5. 4.2 Global Fertility Drugs Sales Volume by Type
  6. 4.2.1 Global Fertility Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Fertility Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Fertility Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Fertility Drugs Sales Value by Type
  10. 4.3.1 Global Fertility Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Fertility Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Fertility Drugs Sales Value Share by Type (2021-2032)
5 Fertility Drugs Market by Application
  1. 5.1 Fertility Drugs Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Fertility Drugs Sales Volume by Application
  5. 5.2.1 Global Fertility Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Fertility Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Fertility Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Fertility Drugs Sales Value by Application
  9. 5.3.1 Global Fertility Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Fertility Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Fertility Drugs Sales Value Share by Application (2021-2032)
6 Fertility Drugs Regional Sales and Value Analysis
  1. 6.1 Global Fertility Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fertility Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Fertility Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Fertility Drugs Sales by Region (2027-2032)
  5. 6.3 Global Fertility Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Fertility Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Fertility Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Fertility Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Fertility Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Fertility Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Fertility Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Fertility Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Fertility Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Fertility Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Fertility Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Fertility Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Fertility Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Fertility Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Fertility Drugs Sales Value Share by Country, 2025 VS 2032
7 Fertility Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Fertility Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fertility Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Fertility Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Fertility Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Fertility Drugs Sales by Country (2027-2032)
  6. 7.4 Global Fertility Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Fertility Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Fertility Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Fertility Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Fertility Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Fertility Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Fertility Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Fertility Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Fertility Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Fertility Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Fertility Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Fertility Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Fertility Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Fertility Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Fertility Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Fertility Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Fertility Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Fertility Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Fertility Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Fertility Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Fertility Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Fertility Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Fertility Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Fertility Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Fertility Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Fertility Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Fertility Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Fertility Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Fertility Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Fertility Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Fertility Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Fertility Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Fertility Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Fertility Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Fertility Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Fertility Drugs Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Fertility Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Fertility Drugs Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Ferring
  14. 8.3.1 Ferring Company Information
  15. 8.3.2 Ferring Business Overview
  16. 8.3.3 Ferring Fertility Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ferring Fertility Drugs Product Portfolio
  18. 8.3.5 Ferring Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Fertility Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Fertility Drugs Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Zydus Pharma
  26. 8.5.1 Zydus Pharma Company Information
  27. 8.5.2 Zydus Pharma Business Overview
  28. 8.5.3 Zydus Pharma Fertility Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zydus Pharma Fertility Drugs Product Portfolio
  30. 8.5.5 Zydus Pharma Recent Developments
  31. 8.6 MSD
  32. 8.6.1 MSD Company Information
  33. 8.6.2 MSD Business Overview
  34. 8.6.3 MSD Fertility Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 MSD Fertility Drugs Product Portfolio
  36. 8.6.5 MSD Recent Developments
  37. 8.7 LIVZON
  38. 8.7.1 LIVZON Company Information
  39. 8.7.2 LIVZON Business Overview
  40. 8.7.3 LIVZON Fertility Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LIVZON Fertility Drugs Product Portfolio
  42. 8.7.5 LIVZON Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fertility Drugs Value Chain Analysis
  2. 9.1.1 Fertility Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fertility Drugs Sales Mode & Process
  6. 9.2 Fertility Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fertility Drugs Distributors
  9. 9.2.3 Fertility Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst